• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

2,6-Diamino-4-(benzyloxy)pyrimidine (CAS No. 100061-59-4): A Versatile Building Block in Medicinal Chemistry and Drug Discovery

The 2,6-Diamino-4-(benzyloxy)pyrimidine (CAS 100061-59-4) is a highly specialized pyrimidine derivative that has garnered significant attention in pharmaceutical research and organic synthesis. This compound, characterized by its diamino and benzyloxy functional groups, serves as a critical intermediate in the development of novel therapeutics, particularly in the fields of kinase inhibitors and anticancer agents. Its unique structural features make it a valuable scaffold for designing molecules with targeted biological activity.

In recent years, the demand for 2,6-Diamino-4-(benzyloxy)pyrimidine has surged due to its role in small-molecule drug discovery. Researchers are increasingly exploring its potential in modulating protein-protein interactions and enzyme inhibition, which are hot topics in precision medicine. The compound's benzyloxy group enhances its lipophilicity, improving membrane permeability—a key consideration in drug bioavailability optimization. This aligns with current industry trends favoring orally bioavailable drugs, a frequent search term among medicinal chemists.

The synthesis of CAS 100061-59-4 typically involves nucleophilic aromatic substitution reactions, a process widely discussed in organic chemistry forums. Its pyrimidine core allows for diverse derivatization, enabling the creation of libraries for high-throughput screening—a technique dominating discussions in AI-driven drug discovery circles. Notably, the diamino substitution pattern at positions 2 and 6 facilitates hydrogen bonding with biological targets, a feature exploited in structure-based drug design.

From a green chemistry perspective—another trending search term—the production of 2,6-Diamino-4-(benzyloxy)pyrimidine has evolved to incorporate catalytic methods and solvent-free conditions, addressing environmental concerns while maintaining yield efficiency. Analytical techniques like HPLC purity analysis and LC-MS characterization ensure batch-to-batch consistency, crucial for GMP-compliant manufacturing—a regulatory requirement frequently queried by quality control professionals.

Beyond pharmaceuticals, this compound shows promise in material science applications, particularly in designing organic semiconductors and coordination polymers. The π-conjugated system of the pyrimidine ring, combined with the benzyloxy moiety, contributes to interesting electronic properties explored in optoelectronic device research—an area gaining traction in renewable energy discussions.

Storage and handling of 100061-59-4 require attention to moisture sensitivity and light protection, common considerations for heterocyclic compounds. Suppliers often highlight these stability parameters in technical datasheets, responding to frequent purchaser inquiries about compound shelf life and storage conditions—topics ranking high in procurement-related searches.

The patent landscape reveals growing interest in 2,6-Diamino-4-(benzyloxy)pyrimidine derivatives, with applications spanning immune-oncology and neurodegenerative disease research. This correlates with rising Google Trends data for "pyrimidine-based therapeutics" and "fragment-based drug discovery", reflecting the compound's relevance in cutting-edge biomedical research.

For synthetic chemists, the regioselective functionalization of this scaffold presents both challenges and opportunities—a subject of numerous research publications and conference presentations. Advanced computational chemistry tools are now employed to predict reactivity patterns, merging traditional synthesis with digital chemistry approaches that dominate contemporary discourse.

In analytical characterization, the 1H-NMR spectrum of 2,6-Diamino-4-(benzyloxy)pyrimidine displays distinctive peaks that serve as fingerprints for quality verification—a practical aspect often searched by analytical chemists troubleshooting compound identification issues. The mass spectrometry fragmentation pattern further aids in structural confirmation, essential for research reproducibility.

As the pharmaceutical industry shifts toward targeted therapies, the versatility of CAS 100061-59-4 ensures its continued importance. Its balanced molecular weight and hydrogen bond capacity align with Lipinski's rule of five parameters—a fundamental concept generating steady search volume among drug development professionals.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)